SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational Phase III clinical trials of its lead product candidate, the ...

Using neutral language with patients and thorough documentation can help mitigate your practice’s legal risks when utilizing ...

Here are 17 facts and business and legal issues about premium intraocular lenses, a recent technology that can free many cataract surgery patients from having to wear eyeglasses. 1. In one of the few ...